kothryn
b
renegar
parker
small
jr
passiv
transfer
matern
immun
respons
keep
mammalian
speci
aliv
process
evolut
develop
effect
mechan
passiv
transfer
system
mucos
immun
mother
offspirng
experiment
passiv
transfer
system
immun
via
serum
antibodi
well
establish
experiment
passiv
transfer
mucos
immun
accomplish
recent
chapter
address
contribut
natur
experiment
mechan
studi
passiv
immun
transfer
system
immun
igg
mother
offspr
occur
prenat
via
placenta
yolk
sac
birth
via
colostrum
speci
vari
contribut
rout
make
transfer
immun
waldman
strober
group
three
categori
tabl
base
variat
first
group
use
prenat
transfer
includ
primat
rabbit
guinea
pig
transport
igg
primat
occur
almost
exclus
placenta
igg
transfer
occur
via
receptormedi
transcytosi
across
syncytiotrophoblast
transcellular
transport
fetal
endothelium
leach
et
al
human
placent
transfer
protect
igg
antibodi
number
pathogen
includ
rotaviru
hjelt
et
al
hepat
b
hockel
kaufman
measl
lennon
black
group
b
streptococcu
baker
et
al
report
prenat
transfer
igg
rabbit
occur
via
yolk
sac
guinea
pig
via
yolk
sac
fetal
gut
waldman
strober
group
use
combin
prenat
postnat
transfer
includ
rat
mice
cat
dog
prenat
transmiss
occur
via
yolk
sacplacenta
fetal
gut
rat
waldman
strober
igg
bound
rapidli
receptor
surfac
yolk
sac
membran
mucchielli
et
al
endocytos
clathrinco
vesicl
earli
gestat
store
subap
vacuol
late
gestat
antibodi
hydrolyz
transfer
fetal
capillari
jolli
prenat
transmiss
mice
occur
similar
mechan
gardner
although
placent
transfer
occur
studi
rodent
shown
transport
antibodi
occur
postnat
colostrum
milk
nejamki
et
al
oda
et
al
kohl
loo
arangojaramillo
et
al
barthold
et
al
heiman
weisman
postnat
transmiss
system
immun
colostrum
milk
occur
period
day
depend
speci
gradual
decreas
transmiss
last
day
period
waldman
strober
limit
antibodi
igg
class
hammerberg
et
al
applebi
catti
transport
receptormedi
process
simist
ree
rat
receptor
found
enterocyt
proxim
intestin
earli
postnat
period
absent
wean
jakoi
et
al
receptor
specif
igg
fc
fragment
consist
two
similar
polypeptid
dalton
associ
microglobulin
jakoi
et
al
simist
mostov
fc
bind
subunit
three
extracellular
domain
transmemban
region
homolog
correspond
domain
class
major
histocompat
complex
mhc
antigen
simist
mostov
rumin
cattl
sheep
goat
hors
pig
review
tizzard
use
postnat
transfer
transport
colostr
protein
lumen
ileum
rumin
larg
nonspecif
hors
pig
igg
igm
absorb
preferenti
protein
taken
activ
epitheli
cell
pinocytosi
pass
cell
lacteal
intestin
capillari
tizzard
intestin
absorpt
occur
first
hour
birth
open
gut
close
transfer
milk
colostrum
occur
waldman
strober
franci
black
elli
etal
tizzard
newborn
piglet
also
shown
absorb
colostr
lymphoid
cell
time
period
absorpt
colostr
immunoglobulin
normal
extrem
effect
suppli
newborn
serum
immunoglobulin
particularli
igg
level
approach
found
adult
tizzard
howev
failur
passiv
transfer
guir
et
al
tizzard
mcguir
studi
fpt
foal
die
infect
within
day
birth
remain
develop
nonfat
respiratori
infect
week
age
mcguir
et
al
also
report
fpt
calv
find
calv
less
week
old
die
infecti
diseas
signific
hypogammaglobulinemia
although
adequ
method
diagnos
treat
fpt
avail
tizzard
berton
et
al
phenomenon
remain
signific
veterinari
problem
mother
milk
provid
passiv
protect
mucos
surfac
contact
protect
may
mediat
nonspecif
factor
found
milk
exampl
lactoferrin
lysozym
fatti
acid
complement
specif
antibodi
review
goldman
et
al
antibodi
composit
milk
differ
colostrum
tizzard
class
protect
antibodi
milk
vari
speci
rout
immun
mother
except
igg
rodent
protect
antibodi
absorb
system
suckl
offspr
exert
protect
effect
local
neutral
virus
virul
factor
bind
microbi
pathogen
prevent
attach
mucos
surfac
goldman
et
al
secretori
iga
especi
suit
protect
role
sinc
secretori
compon
enhanc
resist
proteolyt
enzym
gastric
acid
kenni
et
al
tomasi
zikan
lindh
provid
extra
antibodi
stabil
mucos
secret
rodent
popular
model
studi
passiv
transfer
matern
immun
via
milk
howev
group
anim
major
drawback
model
passiv
mucos
immun
rat
mice
activ
transport
igg
gut
serum
approxim
week
seckathryn
b
renegar
parker
small
jr
tion
thu
observ
protect
could
result
antibodi
milk
bath
mucos
surfac
matern
antibodi
transport
serum
secret
offspr
caveat
kept
mind
evalu
mani
report
milkborn
protect
speci
three
rodent
model
protect
mucos
surfac
due
milkborn
serumderiv
antibodi
describ
predomin
immunoglobulin
mous
milk
igg
although
signific
level
iga
also
present
ijaz
et
al
protect
infant
mice
colon
campylobact
jejuni
achiev
consumpt
immun
milk
time
bacteri
challeng
milk
studi
contain
high
concentr
specif
igg
antibodi
littl
specif
iga
antibodi
infant
mice
protect
prior
consumpt
colostrum
milk
antibodi
requir
gut
lumen
protect
observ
abimiku
dolbi
similar
requir
antibodi
activ
intestin
cell
surfac
murin
immun
primat
rotaviru
report
offit
et
al
rat
protect
dental
cari
milk
due
igg
siga
antibodi
depend
rout
matern
immun
rat
dam
immun
intraven
heatkil
streptococcu
mutan
develop
igg
antibodi
colostrum
milk
serum
offspr
demonstr
signific
protect
mutansmaxxcea
cari
format
rat
dam
local
inject
region
mammari
gland
heatkil
mutan
fed
formalinkil
mutan
develop
siga
antibodi
colostrum
milk
offspr
also
protect
cari
format
michalek
mcghee
cari
protect
suckl
rat
theoret
could
due
either
bath
mucos
surfac
antibodi
leakag
saliva
serum
nonimmun
adult
rat
protect
mwtansinduc
cari
feed
lyophil
immun
bovin
milk
immun
bovin
whey
contain
specif
igg
michalek
et
al
michalek
et
al
sinc
adult
rat
unabl
transport
oral
administ
igg
serum
protect
milkderiv
antibodi
bath
oral
caviti
rumin
sheep
cattl
goat
predomin
antibodi
colostrum
milk
igg
predomin
antibodi
colostrum
pig
hors
also
igg
lactat
progress
colostrum
becom
milk
iga
predomin
tizzard
protect
mediat
either
antibodi
class
wherea
bath
mucos
surfac
milkderiv
antibodi
provid
passiv
immun
pathogen
high
rate
infect
fpt
foal
calv
show
milk
mucos
immun
alon
provid
complet
protect
neonat
cattl
pig
passiv
immun
enter
infect
virus
rotavirus
coronavirus
transmiss
gastroenter
tge
depend
continu
presenc
gut
lumen
protect
level
specif
antibodi
crouch
swine
passiv
immun
intestin
infect
tge
viru
gener
complet
piglet
ingest
iga
antibodi
ingest
igg
antibodi
although
class
antibodi
protect
class
antibodi
present
sow
milk
depend
rout
immun
bohl
saif
cattl
passiv
immun
calf
scour
neonat
bovin
colibacillosi
caus
escherichia
coli
correl
level
specif
iga
antibodi
milk
wilson
jutila
primat
iga
predomin
immunoglobulin
colostrum
milk
tizzard
lysozym
siga
human
milk
remain
bioavail
digest
tract
earli
infant
eschenburg
et
al
human
milk
shown
contain
siga
antibodi
least
five
virus
nine
bacteri
pathogen
well
fungi
parasit
food
antigen
goldman
et
al
mucos
immun
rotaviru
exampl
shown
transfer
infant
siga
milk
posit
correl
found
titer
secretori
compon
mother
milk
infant
fece
virusspecif
iga
found
infant
fecal
sampl
rahman
et
al
addit
provid
passiv
mucos
immun
human
breast
milk
also
stimul
earli
local
product
siga
urinari
gastrointestin
tract
thu
acceler
develop
activ
local
host
defens
system
infant
prentic
koutra
vigorita
sinc
first
transfer
immun
inject
serum
von
behr
kitasato
passiv
transfer
humor
immun
investig
intens
use
specif
serum
antibodi
igg
transfer
protect
nonimmun
individu
becom
routin
common
medic
practic
exampl
postexposur
prophylaxi
rabi
tetanu
treatment
snakebit
arnold
center
diseas
control
b
local
immun
correl
level
iga
variou
secret
tabl
ii
howev
direct
demonstr
mediat
local
immun
inject
iga
could
occur
specif
transport
passiv
administ
iga
confirm
mucos
surfac
rabbit
rat
mice
polymer
iga
transport
effici
circul
bile
via
liver
orlan
et
al
orlan
et
al
delacroix
et
al
koertg
butler
mestecki
mcghee
speci
express
secretori
compon
hepatocyt
socken
et
al
addit
polymer
iga
primari
molecular
form
serum
vaerman
hereman
serum
iga
also
transport
effi
cientli
bile
cattl
butler
et
al
fact
iga
rumin
bile
may
serum
origin
transport
serum
iga
bile
human
report
delacroix
et
al
dooley
et
al
although
iga
transport
less
effici
rat
rabbit
human
biliari
iga
level
approxim
human
serum
iga
level
physiolog
condit
human
biliari
iga
deriv
serum
vaerman
delacroix
although
transport
possibl
passiv
administ
iga
reach
high
level
human
bile
one
studi
less
intraven
inject
radiolabel
polymer
iga
found
human
bile
hr
vaerman
delacroix
subject
review
chapter
serum
polymer
iga
transport
saliva
dog
montgomeri
et
al
monkey
challacomb
et
al
human
delacroix
et
al
kubagawa
et
al
human
amount
iga
acquir
serum
low
serum
compar
amount
acquir
local
product
delacroix
et
al
transfer
polymer
iga
serum
canin
saliva
select
process
requir
secretori
compon
montgomeri
et
al
wherea
transport
oral
fluid
monkey
appear
leakag
plasma
crevicular
space
surround
decidu
molar
challacomb
et
al
sheep
activ
transport
iga
circul
milk
seem
like
sheldrak
et
al
howev
studi
transport
iga
murin
milk
produc
conflict
result
use
radiolabel
iga
halsey
et
al
demonstr
mous
iga
transport
circul
milk
earli
lactat
investig
russel
et
al
koertg
butler
use
assay
base
antibodybind
activ
unabl
show
transport
iga
murin
milk
use
radiolabel
iga
koertg
butler
abl
show
iga
present
milk
degrad
suggest
previou
studi
halsey
et
al
detect
iga
fragment
transud
milk
serum
specif
transport
iga
passiv
administ
iga
transport
milk
rat
dahlgren
et
al
koertg
butler
limit
number
studi
transport
antibodi
respiratori
secret
report
result
shown
select
transport
passiv
administ
serum
iga
respiratori
tract
possibl
sheep
mice
import
background
inform
experi
demonstr
passiv
transfer
local
immun
iga
respiratori
transport
studi
address
detail
sheep
use
intraven
iv
inject
radioiodin
ovin
immunoglobulin
scicchitano
et
al
show
iga
mediastin
lymph
sheep
plasma
deriv
investig
demonstr
scicchitano
et
al
simultan
inject
kathryn
b
renegar
parker
small
jr
radiolabel
iga
radiolabel
igg
igg
iga
transport
select
ovin
respiratori
secret
transport
iga
calcul
hr
postinject
approxim
time
greater
transport
igg
transport
iga
intact
secret
biolog
activ
transport
iga
determin
b
mice
mazanec
et
al
found
hr
iv
inject
radiolabel
monomer
polymer
iga
antisendai
viru
monoclon
antibodi
mice
transport
polymer
iga
nasal
secret
time
effici
transport
monomer
iga
wherea
polymer
iga
transport
bronchioalveolar
la
vage
time
effici
differ
probabl
reflect
increas
contribut
serum
antibodi
bronchioalveolar
secret
transud
igg
alevolar
fluid
transport
polymer
iga
gut
time
effici
transport
monomer
iga
expect
agreement
nasal
secret
gut
transport
indic
suggest
transport
could
occur
similar
mechan
investig
unabl
demonstr
presenc
function
intact
polymer
iga
upper
respiratori
tract
polymer
iga
transport
murin
nasal
secret
studi
report
renegar
small
contrast
function
intact
avoid
problem
associ
quantit
intact
compar
degrad
radiolabel
iga
secret
describ
koertg
butler
studi
use
antiinfluenza
enzymelink
immunosorb
assay
elisa
evalu
transport
monomer
polymer
iga
igg
monoclon
antiinfluenza
antibodi
nasal
secret
mice
antibodi
detect
assay
necess
function
nonimmun
mice
inject
intraven
influenzaspecif
monomer
polymer
iga
igg
sacrif
vari
time
hr
postinject
nasal
wash
serum
bile
sampl
collect
assay
elisa
antiinfluenza
antibodi
peak
nasal
wash
polymer
iga
titer
reach
hr
antibodi
inject
approxim
time
greater
nasal
wash
titer
either
monomer
immunoglobulin
determin
whether
polymer
iga
transport
select
rel
igg
investig
inject
mixtur
two
monoclon
antibodi
intraven
nonimmun
mice
calcul
select
transport
index
sti
nasal
antibodi
mous
sti
greater
indic
polymer
iga
transport
specif
rel
iggj
wherea
valu
indic
extent
transport
leakag
transud
polymer
iga
igg
occur
anim
mice
studi
show
sti
greater
averag
sti
hr
demonstr
select
transport
polymer
iga
rel
iggj
select
transport
polymer
iga
rel
monomer
iga
also
demonstr
thu
transport
serum
iga
nasal
secret
possibl
speci
relev
transport
passiv
transfer
local
immun
address
section
ii
studi
passiv
transfer
local
immun
classifi
two
categori
first
categori
studi
antibodi
introduc
local
secret
exogen
mix
target
pathogen
prior
host
challeng
second
categori
includ
studi
system
administ
polymer
iga
must
transport
physiolog
ie
secretori
componentmedi
mechan
site
activ
studi
categori
investig
role
iga
mucos
immun
feed
antibodi
instil
intranas
challeng
administ
antibodypathogen
mixtur
intranas
oral
antibodi
offit
et
al
demonstr
abil
milkderiv
igg
iga
protect
murin
intestin
infect
primat
rotaviru
suckl
mice
protect
milk
dam
immun
oral
viru
protect
activ
detect
igg
iga
fraction
iga
fraction
potent
vivo
igg
fraction
newborn
mice
immun
dam
fosternurs
seroneg
dam
presenc
circul
system
antirotaviru
antibodi
high
titer
protect
viral
infect
thu
specif
antibodi
present
gut
lumen
protect
intestin
cell
surfac
viral
infect
siga
could
mediat
protect
b
intranas
antibodi
three
studi
shown
exogen
administ
iga
protect
intranas
challeng
pathogen
bessen
fischetti
show
siga
given
intranas
rout
protect
mice
streptococc
infect
live
streptococci
mix
affinitypurifi
human
salivari
siga
serum
igg
antibodi
direct
toward
streptococc
protein
mixtur
administ
intranas
mice
siga
antibodi
protect
streptococc
infect
wherea
serum
antibodi
effect
studi
suggest
siga
alon
capabl
protect
mucosa
bacteri
invas
mazanec
et
al
demonstr
iga
protect
mucos
surfac
viral
infect
ascit
fluid
contain
iga
antisendai
viru
monoclon
antibodi
administ
intranas
lightli
anesthet
mice
mice
challeng
intranas
live
viru
mice
sacrif
day
later
lung
viral
titer
determin
anim
treat
specif
monoclon
antibodi
protect
viral
infect
addit
work
laboratori
show
local
immun
sendai
viru
also
mediat
intranas
igg
mazanec
et
al
tamura
et
al
purifi
antiinfluenza
siga
antibodi
respiratori
tract
mice
immun
influenza
hemagglutinin
molecul
iga
given
intranas
protect
nonimmun
mice
influenza
infect
protect
observ
day
antibodi
administr
proport
amount
iga
administ
observ
iga
dose
equival
natur
occur
antibodi
titer
studi
show
local
iga
igg
protect
viral
bacteri
infect
mucosa
show
physiolog
transport
secretori
iga
serumderiv
igg
actual
demonstr
antibodi
must
administ
parenter
transport
mucos
secret
physiolog
mechan
studi
present
next
section
satisfi
criterion
definit
studi
categori
involv
respiratori
gastrointestin
tract
although
passiv
transfer
uterin
immun
polymer
iga
also
observ
k
b
renegar
c
meng
p
small
jr
j
mestecki
unpublish
result
work
respiratori
gastrointestin
tract
present
detail
respiratori
tract
numer
studi
shown
passiv
administ
serum
antiinfluenza
antibodi
igg
prevent
lethal
viral
pneumonia
loosli
et
al
barber
small
ramphai
et
al
kri
et
al
serum
antibodi
howev
prevent
influenza
infect
upper
respiratori
tract
barber
small
ramphai
et
al
kri
et
al
protect
nose
correl
increas
nasal
secret
iga
antibodi
level
tabl
ii
make
influenza
excel
model
investig
hypothesi
nasal
immun
mediat
siga
first
demonstr
passiv
transfer
local
immun
physiolog
transport
siga
report
renegar
small
murin
influenza
model
research
show
describ
section
ii
b
intraven
administ
polymer
iga
transport
nasal
secret
physiolog
manner
determin
whether
intraven
administ
polymer
iga
antiinfluenza
monoclon
antibodi
could
mediat
protect
local
influenza
viru
challeng
passiv
immun
mice
challeng
intranas
awak
influenza
viru
mice
sacrif
hr
later
amount
viru
shed
nasal
secret
determin
salineinject
control
mice
shed
viru
nasal
secret
wherea
polymer
igainject
mice
shed
viru
shed
viru
low
viral
titer
observ
protect
signific
p
passiv
immun
influenzaspecif
polymer
iga
therefor
confer
complet
protect
viral
infect
mice
partial
protect
remain
determin
whether
serum
igg
also
could
confer
local
protect
influenza
challeng
rel
abil
equival
virusneutr
dose
influenzaspecif
polymer
iga
igg
protect
influenza
challeng
compar
intraven
polymer
iga
significantli
reduc
viral
shed
compar
either
intraven
salin
intraven
iggj
intraven
igg
also
reduc
viral
shed
p
howev
protect
infect
signific
p
sinc
viral
shed
prevent
mice
inject
addit
studi
k
b
renegar
p
small
jr
unpublish
result
shown
igg
also
mediat
local
protect
influenza
infect
time
polymer
iga
protect
dose
requir
produc
protect
passiv
protect
studi
show
iga
mediat
local
immun
confirm
iga
mediat
local
immun
method
abolish
igamedi
protect
need
mice
passiv
immun
polymer
iga
given
nose
drop
antiiga
antibodi
min
hr
challeng
intranas
influenza
viru
suspend
antiiga
antiserum
antiiga
treatment
abrog
igamedi
protect
passiv
immun
mice
renegar
small
show
passiv
transfer
local
immun
iga
reflect
natur
situat
abrog
techniqu
extend
mice
convalesc
influenza
infect
renegar
small
nonimmun
mice
convalesc
mice
mice
recov
influenza
viru
infect
week
earlier
therefor
natur
immun
treat
intranas
antiserum
iga
igg
mixtur
antisera
igg
igm
challeng
awak
influenza
viru
mix
antiserum
intranas
administr
antiserum
continu
interv
hr
mice
kill
day
viral
challeng
nasal
wash
assay
viru
shed
figur
nonimmun
mice
becam
infect
regardless
whether
viru
administ
salin
normal
rabbit
serum
antiimmunoglobulin
antiserum
convalesc
mice
expect
protect
viral
infect
administr
influenza
viru
either
antiigg
mixtur
antiigg
antiigm
antisera
affect
protect
convalesc
mice
still
immun
administr
viru
antiiga
antiserum
howev
abrog
convalesc
immun
result
show
iga
major
sole
mediat
mucos
immun
influenza
viru
murin
nose
suggest
passiv
immun
mimic
role
siga
play
natur
immun
b
gastrointestin
tract
addit
evid
secretori
iga
mediat
local
immun
come
studi
gastrointestin
tract
polymer
iga
hybridoma
vibrio
cholera
gener
result
monoclon
antibodi
use
determin
whether
iga
mediat
immun
toward
bacteri
pathogen
gut
winner
et
al
investig
select
clone
produc
dimer
monoclon
iga
antibodi
direct
ogawaspecif
lipopolysaccharid
carbohydr
antigen
expos
bacteri
surfac
antibodi
abl
crosslink
bacteri
organ
vitro
suggest
might
effect
prevent
mucos
colon
pathogen
vivo
provid
continu
physiolog
ie
nonimmun
convalesc
mice
treat
antiigg
convalesc
control
mice
treat
salin
experi
nonimmun
convalesc
mice
treat
antiigg
antiigm
convalesc
control
mice
treat
salin
eid
egg
infect
dose
reprint
permiss
renegar
small
secretori
componentmedi
transport
specif
antibodi
gut
hybridoma
cell
inject
subcutan
back
adult
balbc
mice
backpack
tumor
releas
monoclon
iga
circul
serum
iga
transport
gut
lumen
neonat
mice
bear
backpack
tumor
surviv
challeng
v
cholera
wherea
neonat
mice
bear
backpack
tumor
unrel
iga
hybridoma
nontumorbear
neonat
mice
die
ingeni
model
provid
first
evid
secretori
iga
alon
mediat
mucos
immun
bacteri
pathogen
serv
second
exampl
passiv
transfer
local
immun
iga
gener
approach
passiv
parenter
transfer
mucos
immun
use
research
tool
determin
role
siga
protect
pathogen
mucos
surfac
possibl
therapi
passiv
administ
ig
antibodi
problemat
gener
gastrointestin
protect
feed
specif
antibodi
certainli
possibl
alreadi
report
cattl
tsunemitsu
et
al
passiv
protect
inject
howev
highli
specul
question
effici
transport
target
mucos
surfac
potenti
advers
effect
intraven
iga
antibodi
serum
iga
associ
decreas
complement
activ
russel
et
al
decreas
immun
lysi
griffiss
goroff
system
administ
polymer
iga
may
also
highli
suppress
specif
humor
cellular
respons
k
b
renegar
taylor
p
small
jr
unpublish
observ
thorough
knowledg
role
iga
play
regul
immun
respons
need
passiv
mucos
immun
via
parenter
antibodi
administr
becom
accept
mean
therapi
human
